Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$150,984
+$20,490 QoQ
Shares Held
600
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#3,988
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VISION FINANCIAL MARKETS LLC holds $2,214,192 across 9 Drug Manufacturers - General names. ABBV ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,626 | $1,174,865 | |
| 2 | LLY |
ELI LILLY & Co
|
380 | $455,783 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,186 | $152,401 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
600 | $150,984 | |
| 5 | PFE |
Pfizer Inc
|
5,752 | $138,508 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,261 | $72,658 | |
| 7 | BIIB |
Biogen Inc.
|
200 | $43,212 | |
| 8 | AZN |
Astrazeneca PLC
|
76 | $14,411 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,984 | 600 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $130,494 | 600 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $205,641 | 900 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $208,386 | 900 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $167,058 | 900 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $188,568 | 900 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $159,930 | 900 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||